Research Topics
Species | Barry ReisbergSummaryAffiliation: New York University School of Medicine Country: USA Publications
| Collaborators
|
Detail Information
Publications
Outcome over seven years of healthy adults with and without subjective cognitive impairmentBarry Reisberg
Silberstein Aging and Dementia Research Center, New York University School of Medicine, New York, USA
Alzheimers Dement 6:11-24. 2010....
A 24-week open-label extension study of memantine in moderate to severe Alzheimer diseaseBarry Reisberg
Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA
Arch Neurol 63:49-54. 2006..This study is an extension of a 28-week, randomized, double-blind, placebo-controlled study of memantine in 252 patients with moderate to severe Alzheimer disease...- Mild cognitive impairment (MCI): a historical perspectiveBarry Reisberg
Aging and Dementia Research Center, New York University School of Medicine, New York 10016, USA
Int Psychogeriatr 20:18-31. 2008..Nevertheless, longitudinal and other studies indicate essential compatibility between GDS stage 3 MCI and Petersen's MCI duration and outcomes... 
Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive declineSusan De Santi
Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA
Neuropsychology 22:469-84. 2008..These findings indicate that Robust norms improve identification of healthy individuals who will decline and may be useful for selecting at-risk participants for research studies and early interventions...- The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer's diseaseBarry Reisberg
Silberstein Aging and Dementia Research Center, New York University School of Medicine, New York, NY, USA
Alzheimers Dement 4:S98-S108. 2008..Subjective cognitive impairment (SCI) has been a common, but poorly understood condition, frequently occurring in older persons... - FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's diseaseLisa Mosconi
Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA
Eur J Nucl Med Mol Imaging 36:811-22. 2009.... - An entorhinal cortex sulcal pattern is associated with Alzheimer's diseaseJiong Zhan
Department of Psychiatry, New York University School of Medicine, New York 10016, USA
Hum Brain Mapp 30:874-82. 2009..We classified the lateral EC sulcal boundary as either a rhinal or collateral pattern and tested the hypotheses that the rhinal pattern was (1) more common in AD and (2) associated with a smaller EC size... - Global measures: utility in defining and measuring treatment response in dementiaBarry Reisberg
Department of Psychiatry, New York University School of Medicine, Silberstein Aging and Dementia Research Center, New York, NY 10016, USA
Int Psychogeriatr 19:421-56. 2007..For Mild Cognitive Impairment (MCI), global severity scales already appear to be one modality for the sensitive assessment of change. The CIBIC-Plus procedures might also productively be applied in future MCI therapeutic trials... - Staging: relevance for trial design in vascular burden of the brainBarry Reisberg
William and Sylvia Silberstein Aging and Dementia Research Center, New York University School of Medicine, NY 10016, USA
Int Psychogeriatr 15:231-9. 2003..Although temporal and prognostic aspects have been studied for the Alzheimer's-related portions of this clinical staging continuum, they remain to be elucidated for cerebrovascular small vessel disease... - Subjective memory complaints: presence, severity and future outcome in normal older subjectsLidia Glodzik-Sobanska
Center for Brain Health, New York University School of Medicine, New York, NY 10016, USA
Dement Geriatr Cogn Disord 24:177-84. 2007..Subjective memory complaint (SMC) in normal individuals may predict future cognitive decline. The goal of this study was to examine whether the probability of decline increases with growing intensity of complaint... - Memantine in moderate-to-severe Alzheimer's diseaseBarry Reisberg
Department of Psychiatry, New York University School of Medicine, New York 10016, USA
N Engl J Med 348:1333-41. 2003..Overstimulation of the N-methyl-D-aspartate (NMDA) receptor by glutamate is implicated in neurodegenerative disorders. Accordingly, we investigated memantine, an NMDA antagonist, for the treatment of Alzheimer's disease... - Evidence and mechanisms of retrogenesis in Alzheimer's and other dementias: management and treatment importBarry Reisberg
Alzheimer's Disease Education and Resources Program, New York University School of Medicine, New York, USA
Am J Alzheimers Dis Other Demen 17:202-12. 2002..A science of AD management can be formulated on the basis of the DA of the Alzheimer's patient, taking into consideration differences of AD from normal development as well as homologies... - Diagnostic criteria in dementia: a comparison of current criteria, research challenges, and implications for DSM-VBarry Reisberg
Department of Psychiatry and Silberstein Aging and Dementia Research Center, New York University School of Medicine, New York, NY 10016, USA
J Geriatr Psychiatry Neurol 19:137-46. 2006..quot; DSM-V should incorporate continuing advances in the neuroscience knowledge base and understanding of these disorders...